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Summary.-The demonstration that hexamethylphosphoramide (HMPA) possesses
potent carcinogenic properties has raised doubts about the safety of exposure to other
phosphoric amides. In order to define a suitable short-term test with which to
evaluate such analogues, the response of the Salmonella typhimurium mutation
assay of Ames and cell transformation assay of Styles to HMPA and 3 selected
analogues has been studied. These analogues were the related leukaemogen phos-
phoramide, the putative non-carcinogen, phosphoric trianilide and N.N'N"-tri-
methylphosphorothioic triamide, a compound ofunknown and hitherto unpredictable
properties. While both tests found the trianilide negative, the Ames test failed to
detect phosphoramide as positive and gave an erratic and predominantly negative
response to HMPA. In contrast, the transformation assay found both phosphoramide
and HMPA positive. This test response profile indicates that the transformation
assay is the preferred test with which to evaluate analogues of HMPA for potential
carcinogenicity. Some structural requirements for potential carcinogenicity within
this class of compounds are tentatively deduced.
A RECENT inhalation study has demoni-
strated that the widely used solvent
hexamethylphosphoramide (HMPA) (I in
Fig. 3) is a powerful rodent carcinogen
(Zapp, 1975). Since this property had
not previously been associated with phos-
phoric amides, it became of interest to
investigate how general this effect was
among compounds structurally related to
HMPA. Although unexpected (Kimbrough
and Gaines, 1973), the carcinogenicity
observed for HMPA has a possible pre-
cedent in the earlier observation that
the parent compound, phosphoramide
(II), produces leukaemia in mice (Vasela,
1962). For this reason (II) was included
in the present study. Conversely, although
the carcinogenic anti-tumour agent tri-
ethylenephosphoramide (III) (Hadidian et
al., 1968) possesses marked structural
similarities to HMPA, it was not con-
sidered relevant to this study as it contains
3 aziridine rings which would, by them-
selves, dominate any biological response.
Although the carcinogenicity of HMPA
may be uniquely associated with this
particular phosphoric amide, it is more
likely that a number of structurally
related compounds such as hexaethyl-
phosphoramide (IV) will share this pro-
perty. However, when considering ana-
logues less obviously related to HMPA,
the assessment of their likely in vivo
properties is difficult, and the use of
a short-term test for carcinogenicity
becomes desirable.
Selection of test system
The initial phase of short-term test
evaluation (McCann and Ames, 1976;
McCann et al., 1975; Purchase et al.,
1976; Brookes and de Serres, 1976) has
concentrated on the ability of a test
to detect carcinogenic activity within the
various classes of chemical carcinogens.
Although several tests are able to detect
more than 900 ° of these carcinogens,
each test is variously insensitive to someCARCINOGENICITY OF HMPA AND DERIVATIVES
carcinogens or classes of carcinogens.
When structural analogues of an estab-
lished or new carcinogen are to be evalu-
ated with an in vitro test the selection
of the most appropriate test is influenced
by three main factors.
(1) The test should be capable of
distinguishing between carcinogens and
non-carcinogens of a variety of chemical
classes, that is, the test should have
been adequately validated. There were 2
such tests available to us for the present
study, namely, the Salmonella typhi-
murium mutation assay (Ames, McCann
and Yamasaki, 1975) and a cell-trans-
formation assay (Styles, 1977).
(2) The sensitivity of the test to the
particular class of potential carcinogens
should be assessed by its ability to give
a reproducible positive result with the
reference carcinogen of the class (in
this case HMPA). In particular, when
studving a new class of potential carcino-
gens, it is important that the test can
detect as positive the parent carcinogen
before assessing the significance of a
negative result given by an analogue.
(3) The test should consistently identify
as negative a non-carcinogenic analogue
of the reference carcinogen (in the absence
of a clearly defined non-carcinogen in
the present class, phosphoric trianilide (V)
was selected, for reasons discussed later).
This requirement ensures that the test
is responding positively to a property
of individual compounds which is asso-
ciated with in vivo carcinogenic activity
rather than to some non-specific property
of the class as a whole.
Having selected the most appropriate
test for a given class of compounds,
positive and negative controls of the
same chemical class can be used to
monitor subsequent experiments with
analogues. As demonstrated in the present
study, the continued sensitivity of a
test to carcinogenicity within a given
class of compounds cannot automatically
be relied upon.
MATERIALS AND METHODS
Chemicals. Hexamethylphosphoramide (I)
was obtained fromn BDH Chemicals Ltd,
Poole, Dorset, U.K., minimum assay 990o
and was used without further purification.
Phosphoric trianilide (V), m.p. 212-215°C
(Autenrieth and Rudolph, 1900; mp 212-
215°) and N,N'N"-trimethylphosphorothioic
triamide (VI), m.p. 106°C (Arceneaux et
al., 1959) w%Nere both obtained from ICI
Organics Division. Phosphoramide (II) was
prepared by the method of Klement and
Koch (1954). During recrystallization of
this product from methanol the period of
heating was kept to a minimum to reduce
decomposition. The product w%as dried over
P205 in a vacuum desiccator at room tem-
perature for 24 h., m.p. 168-1690C (decom-
position) (no literature on m.p. available)
and stored in a desiccator at 0°C. Analysis:
calc. for 1160N3P: H, 6-3; N, 44.20; obs:
H, 6-1; N, 41-9%; mass equiv. ratio, 95
(molecular ion) (AEI MS9 mass spectro-
meter). Attempts to improve the nitrogen
analysis figure were unsuccessful; even brief
periods of heat drying at 50°C resulted in a
further apparent loss of niitrogen. Analysis
of an aged sample of this material indicated
that it had adsorbed CO2. Although the
analytical data for this compound are
equivocal it seems likely that it is the
same material as that used by Vasela
(1962).
The Ames test.-The method wras that of
Ames et al. (1975). Muutant strains of the
bacteria Salnonella typhimuraium (TA1535,
TA1538, TA98 and TAIOO) -were obtained
from Professor B. N. Ames, Berkeley,
California, U.S.A., and -wereregularly checked
for their knomn characteristics (Ames et
al., 1975).
Cells were grown to a density of about
109/ml and then distributed in 0 1-ml
volumes into bijou bottles so as to give
an eventual cell density of 108/plate. Rat
liver post-mitochondrial supernatant was
prepared by the method described by Ames
et al. (1975) from rats (Sprague-Dawley;
ICI Breeding Unit, Alderley Park) induced
with Aroclor 1254 (Anlabs IInc., North
Haven, Conn., U.S.A.). The liver supernatant
was stored at -80°C and before use mixed
in a 1 : 3 ratio with cofactor (8-9 mix;
Ames et al., 1975). The test compounds, at
various eoncentrations in dimethylsulph-
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oxide (DMSO) (BDH Chemicals Ltd, Poole,
Dorset), were added in 041-ml aliquots to
the bacterial tester strain in the bijou
bottle. Compounds waere tested over the
concentration range of 2500, 500, 100, 20
and 4 ,ug/plate. The S-9 mix (0-15 ml) was
added to each bottle followed by 2 ml of
molten agar and the mixture poured on to
9-cm diameter plates containing 30 ml V7ogel-
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Bonner minimal medium with 1.5%° Bacto
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Fic. 1.-Survival aid(l transfoImatioin of BHK
cells treate(I with compotuncs (I) (a), (II)
(b), (V) (e), (VI) (d), benzidine (e,
00-* ) anid DAIS() (e, A A A).
D)ashed lines represe,nt 50% survival (and
LD50) ani(I 2530 trarasformants per 06 St,,.-
vivorsi (i.e. 5 X control frequency).
Comupany) and 2-(1-chloro-2-isopropylamino-
ethyl) naphthalene (ICl Pharmaceuticals
Division)] wNN,ere used at suitable concentra-
tions in 0-1 ml of DAISO. DMSO wAas used
as a negative control. The numbers of
revertant colonies per plate were counted
with a Biotran Colony Counter (Model
C III). A positive result was recorded when
the number of revertant colonies on a test
plate exceeded twice the control number
of spontaneous revertants for that tester
strain.
Cell transforriatioi test.-The methods
employed wNhen testing a compound for
potential carcinogenicity using growth of
manmmalian cells in semni-solid agar have
been described in detail in the previous paper
(Styles, 1977). A positive result is recorded
when the transformiation frequency per 106
suirvivors at the LD50 exceeds 5 x the
control firequency per 106 survivors. Trhe
cells used in this study Awere BHK 21/Cl 13,
wAhich had a spontaneous transformation
frequency of 50 per 106 survivors.
RESULTS
The method of evaluating each test
was the same. Two experiments were
conducted with each test, the first using
HMPA (I), the trianilide (V) and phos-
phoramide (II) and the second with
phosphoramide (II) replaced by the thio-
amide (VI). Both experiments in each
test were accompanied by negative con-
trols and controls known to be positive in
that system.
Arnes test
In the first experiment, HMPA gave
a strong, dose-related, positive effect in
strains TA1535 and TA100, in the presence
of S-9 mix (up to 29-fold increase in
revertant colonies in TA1535, and 10-fold
in TAIOO). Phosphoramide (II) and the
trianilide (V) were both negative. In
the second experiment, HMPA, together
with the phosphoramides (V) and (VI)
were all negative. A summary of these
results is given in the Table. The un-
reliable nature of the Ames test response
for HMPA has been confirmed by us in
several subsequent experiments. More-
over, when tested in an independent
contract laboratory, a consistent negative
response was obtained (D. McGregor,
personal communication); the positive
control compounds were correctly identi-
fied in each ofthe above experiments.
Cell transformation test
The transformation frequencies (cor-
rected to a theoretical LDo) and the cell
survivals obtained after treatment of the
cells with HMPA (I) (Fig. la), phos-
phoramide (II) (Fig. lb), the trianilide
(V) (Fig. Ic) and the thioamide (VI)
(Fig. Id) are shown. Both experiments
were conducted using duplicate plates at
each dose level. Benzidine was used as
a positive control and DMSO as negative
control (Fig. le).
A summary of the results obtained
is shown in the Table. Phosphoramide
(II) and HMPA (I) gave positive results
oIn each occasion and the trianilide (V)
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FIG. 2. Survival and transformation dose
response curves of BHK cells treated with
diphenylnitrosamine ( * A ) and di-
methylnitrosamine ( 0 O ). Dashed
lines represent 50% survival(andl LD50) and
250 transformants per 106 survivors (i.e. 5
x control frequency).
and the thioamide (VI) gave negative
results. The results for dimethylnitros-
amine and diphenylnitrosamine were ob-
tained under similar conditions and are
recorded here for comparison (Fig. 2).
Full details of these experiments will be
published elsewhere.
DISCUSSION
The object of the present study was
to define an appropriate short-term test
with which to evaluate the potential
carcinogenicity of chemical relatives of
HMPA and, further, to attempt to find
a chemical explanation for its carcino-
genicity. The results shown in the Table
clearly establish that only the cell trans-
formation test meets the criteria described
earlier and it is, therefore, the preferred
assay for this class of compounds. Further
the data obtained provide a basis for
understanding the in vivo and in vitro
effects so far observed.
Consideration will first be given to the
possible ways by which the carcino-
genicity of the HMPA could be mediated.
First, an intermediate alkylating species
might arise from the dimethylamino group
which is present in this compound. This
functional group has been directly impli-
cated in the carcinogenic activation
of several other carcinogens such as
dimethylnitrosamine, dimethylcarbamoyl
chloride and 4-dimethvlaminoazobenzene.
Alternatively, the in vrio effect may
derive from purely physical interactions
associated with the unusual lipid-aqueous
solvent properties of HMPA (Lloyd,
1975) which is a liquid. In this con-
nection, it may be significant that the
primary tumours observed in the rat
inhalation study occurred in the imme-
diate nasal region. Neither of these
possible methods of action can apply to
phosphoric trianilide (V) which is a solid
(m.p. 212-215°C) and which is also
devoid ofpotential alkylating groups.
The positive effects given by HMPA
in these two short-term tests, together
with the fact that it produces mutagenic
effects in Drosophila (Bemes and Sram,
1969) supports the view that this com-
TABLE. Results Given by the Ames Test and the Cell Transformation Test for Hexa-
rnethylphosphoramide (I), Phosphoramide (II), Phosphoric Trianilide (V) and
N,N'N"-Trimethylphosphorothioic Triamide (VI)
Experiment
Ames test
1
2
Cell transformation
1
2
(I)
(+ve control)
+~~
Compound
(V)
(II) (VI) (-ve control)
568CARCINOGENICITY OF HMPA AND DERIVATIVES
CH3 CH3
CH3 lN CH3
(I)
NH2
HrN P NH2
11
(II
Et
-N
I,t
NHPh
PhiIN P-NHPh
11
(V)
CH,
N-N-O
(VII)
00
N
N
11
u
NHCH3
CH3HN P NHCH3
S
(VI)
Ph
N-Nz~O
Ph
(VIII)
COx
N
N
11
u
(IX) (X)
FIe. 3.-Structural formulae of compounds mentioned in text.
pound, or an active metabolite of it,
reacts chemically with genetic material.
Further, the negative response observed
in the present study for the phenyl
analogue (V), which is devoid of methyl
groups, implicates the methyl groups in
this process. These results equally make
the non-specific physical hypothesis less
plausible, as the functionally related
dipolar solvents dimethylformamide
(DMF) and dimethylsulphoxide (DMSO)
are without effect in both tests (Purchase
et al., 1976).
The difference in test response observed
when comparing HMPA with the phenyl
analogue (V) (Figs. la and c) is similar
to that found when comparing the test
response for the carcinogenic biological
alkylating agent, dimethylnitrosamine
(VII) with its non-carcinogenic, phenyl-
ated analogue, diphenylnitrosamine (VIII)
(Fig. 2). The analogy between these 2
classes of carcinogen is further strength-
ened by the fact that the erratic response
given by the Ames test for HMPA has
also been observed for dimethylnitros-
amine (Bartsch, Camus and Malaveille,
1976; Purchase et al 1976, 1977 in prepar-
ation) when using the same plate incor-
poration technique. It may be that both
these erratic responses are due to varia-
tions in the rate of formation or effective
half-life of a common alkylating species.
Such variations could result from changes
in the enzyme profile, or balance between
different batches of microsomes, or from
slight changes in the chemical environ-
ment in the test medium.
7
N
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0
(III)
Et Et
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There is, therefore, sufficient evidence
to assume initially that the broad struc-
tural requirements for carcinogenicity ob-
served for the nitrosamine carcinogens
apply equally to phosphoric amides.
The structure-activity relationships ob-
served for nitrosamines have been re-
viewed (Druckrey, 1J975) and the major
requirement for activity is that the
amine nitrogen atom should carry at
least one alkyl group having a free
ct-position potentially capable of under-
going metabolic ca-hydroxylation. On this
basis, it is possible to predict that hexa-
ethylphosphoramide (IV) and phosphoric
trimorpholide (IX), for example, would
both have carcinogenic potential by ana-
logy with the carcinogens diethylnitros-
amine and nitrosomorpholine (X) re-
spectively. Clearly, the first step in the
evaluation of such compounds would be
to submit them to the cell transformation
test, with HMPA as the positive control.
The validity of the above chemical
class analogy is partially confirmed by
the observation that HMPA, and 2
of its alkylated analogues, undergo in
vivo and in vitro a-hydroxylation leading
to formaldehyde formation (Jones and
Jackson, 1968). We have confirmed this
observation for HMPA using the 8-9
liver fraction described above, a dose-
dependent relationship between the con-
centration of HMPA and formaldehyde
formation being observed. These experi-
ments, which mirror those described for
dimethylnitrosamine (McLean and Day,
1974) together with others aimed at
trapping the postulated intermediate al-
kylating species formed from HMPA will
be described in a subsequent publication.
The usefulness of a reliable test is
illustrated by the problem posed when
attempting to evaluate a compound such
as the thioamide (VI). This compound
is superficially related to HMPA, yet it
has no counterpart in nitrosamine chemis-
try. The negative result obtained (Fig.
Id) indicates that this compound can be
dissociated from the HMPA-type in vivo
carcinogenesis.
Finally, it must be mentioned that
the in vitro test response and the in
vivo leukaemogenicity observed for phos-
phoramide (II) require an explanation
not involving alkyl groups (since none is
present). Any separate hypothesis might,
of course, be additionally involved in
explaining the carcinogenic activity of
HMPA itself. Curiously, a similar situation
is encountered when considering the car-
cinogenicity of derivatives of hydrazine
(NH2.NH2) (Toth, 1975). In this case the
activity of a variety of alkylated hydra-
zines can be explained in terms of derived
carbonium ions, yet this leaves the
activity observed for hydrazine itself
unexplained (Biancifiori and Ribacchi,
1962).
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